Researchers at Israel’s Weizmann Institute have overcome the resistance of the most aggressive forms of multiple myeloma. In a trial of 41 patients at 15 Israeli hospitals they discovered that Cyclosporin A neutralizes the disease’s resistance to cancer-killing proteasome inhibitors.
https://wis-wander.weizmann.ac.il/life-sciences/uncovering-anti-myeloma-resistance-files